TCTMD

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

MINNEAPOLIS – Medtronic, Inc. has reached two clinical program milestones for its CoreValve® System in the United States. First, it completed enrollment in its study of high risk patients in its ...
TCTMD

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

EuroPCR Presentation of "Real World" ADVANCE Study Confirms Economic Value of Novel Self-Expanding Valve in Patients Unable to Undergo Surgery PARIS -- Focused on offering devices that provide both ...
MD&M East

Medtronic Wins FDA Nod For CoreValve TAVR Device for High-Risk Patients

Less than six months after Medtronic got FDA approval for it CoreValve Transcatheter Aortic Valve Replacement system for patients who cannot undergo open-heart surgery, the Minnesota company announced ...
MD&M East

Medtronic to Appeal Edwards Court Win Blocking CoreValve in U.S.

Almost before the judge's signature was dry on Friday's federal district court preliminary injunction in favor of Edwards Lifesciences Corp. (Irvine, CA) that will block Medtronic from selling its ...
Business Wire

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...
Business Wire

Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve ® Transcatheter Aortic Valve System

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), announced today that it will appeal the $73.5 million jury verdict returned in the U.S. District Court in Delaware deciding that the ...
Benzinga.com

Medtronic CEO On The Company's New Valve Product And How Covidien's Integration Is Progressing

"Well we are really excited about this product," Ishrak began. "This is an upgrade to our existing CoreValve transcatheter valve product. It makes the device repositionable and recapturable, which is ...
The Business Journals

Medtronic hit with $106M verdict in patent fight with Colibri Heart Valve

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A federal jury in California ...
Reuters

Edwards Lifesciences wins appeal in Medtronic patent fight

WASHINGTON (Reuters) - Edwards Lifesciences LLC Corp won a round in a patent fight with Medtronic Inc's CoreValve unit on Tuesday as a federal appeals court upheld a $74 million lower court judgment ...
MedCity News

Medtronic not barred from making CoreValve device, judge decides

Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...
Reuters

Survival rate with Medtronic's CoreValve tops surgery -study

WASHINGTON, March 29 (Reuters) - Medtronic Inc's minimally invasive CoreValve system for replacing diseased aortic heart valves led to a significantly higher survival rate after one year than ...